ID   BLK_HUMAN               Reviewed;         505 AA.
AC   P51451; Q16291;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 3.
DT   02-NOV-2010, entry version 102.
DE   RecName: Full=Tyrosine-protein kinase Blk;
DE            EC=2.7.10.2;
DE   AltName: Full=B lymphocyte kinase;
DE   AltName: Full=p55-Blk;
GN   Name=BLK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=95123078; PubMed=7822795;
RA   Islam K.B., Rabbani H., Larsson C., Sanders R., Smith C.I.;
RT   "Molecular cloning, characterization, and chromosomal localization of
RT   a human lymphoid tyrosine kinase related to murine Blk.";
RL   J. Immunol. 154:1265-1272(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=95148218; PubMed=7845672;
RA   Drebin J.A., Hartzell S.W., Griffin C., Campbell M.J.,
RA   Niederhuber J.E.;
RT   "Molecular cloning and chromosomal localization of the human homologue
RT   of a B-lymphocyte specific protein tyrosine kinase (blk).";
RL   Oncogene 10:477-486(1995).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [4]
RP   FUNCTION AS REGULATOR OF INSULIN SECRETION, TISSUE SPECIFICITY,
RP   INVOLVEMENT IN MODY11, VARIANT THR-71, AND CHARACTERIZATION OF VARIANT
RP   THR-71.
RX   PubMed=19667185; DOI=10.1073/pnas.0906474106;
RA   Borowiec M., Liew C.W., Thompson R., Boonyasrisawat W., Hu J.,
RA   Mlynarski W.M., El Khattabi I., Kim S.H., Marselli L., Rich S.S.,
RA   Krolewski A.S., Bonner-Weir S., Sharma A., Sale M., Mychaleckyj J.C.,
RA   Kulkarni R.N., Doria A.;
RT   "Mutations at the BLK locus linked to maturity onset diabetes of the
RT   young and beta-cell dysfunction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:14460-14465(2009).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-48; THR-71 AND THR-71.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Modulator of beta-cells function, acting through the up-
CC       regulation of PDX1 and NKX6-1 and consequent stimulation of
CC       insulin secretion in response to glucose.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- TISSUE SPECIFICITY: Expressed in lymphatic organs, pancreatic
CC       islets, Leydig cells, striate ducts of salivary glands and hair
CC       follicles.
CC   -!- DISEASE: Defects in BLK are a cause of maturity-onset diabetes of
CC       the young type 11 (MODY11) [MIM:613375]. MODY11 is a form of
CC       diabetes that is characterized by an autosomal dominant mode of
CC       inheritance, onset in childhood or early adulthood (usually before
CC       25 years of age), a primary defect in insulin secretion and
CC       frequent insulin-independence at the beginning of the disease.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z33998; CAA83965.1; -; mRNA.
DR   EMBL; S76617; AAB33265.1; -; mRNA.
DR   IPI; IPI00941870; -.
DR   PIR; I37206; I37206.
DR   RefSeq; NP_001706.2; -.
DR   UniGene; Hs.146591; -.
DR   ProteinModelPortal; P51451; -.
DR   SMR; P51451; 63-505.
DR   IntAct; P51451; 2.
DR   MINT; MINT-1494192; -.
DR   STRING; P51451; -.
DR   PhosphoSite; P51451; -.
DR   PRIDE; P51451; -.
DR   Ensembl; ENST00000259089; ENSP00000259089; ENSG00000136573.
DR   GeneID; 640; -.
DR   KEGG; hsa:640; -.
DR   UCSC; uc003wty.1; human.
DR   CTD; 640; -.
DR   GeneCards; GC08P011388; -.
DR   H-InvDB; HIX0007315; -.
DR   HGNC; HGNC:1057; BLK.
DR   HPA; CAB005093; -.
DR   MIM; 191305; gene.
DR   MIM; 613375; phenotype.
DR   Orphanet; 552; MODY syndrome.
DR   PharmGKB; PA25368; -.
DR   eggNOG; prNOG04145; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P51451; -.
DR   PhylomeDB; P51451; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; amb2_neutrophils_pathway; amb2 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kcipathway; Class I PI3K signaling events.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrinbrevpathway; Ephrin B reverse signaling.
DR   Pathway_Interaction_DB; glypican_1pathway; Glypican 1 network.
DR   Pathway_Interaction_DB; pdgfrbpathway; PDGFR-beta signaling pathway.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; ptp1bpathway; Signaling events mediated by PTP1B.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   NextBio; 2596; -.
DR   ArrayExpress; P51451; -.
DR   Bgee; P51451; -.
DR   CleanEx; HS_BLK; -.
DR   Genevestigator; P51451; -.
DR   GermOnline; ENSG00000136573; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; TAS:ProtInc.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR020750; Tyr_kinase_non-rcpt_Blk.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF261; Tyr_kinase_non-rcpt_Blk; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; FALSE_NEG.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Diabetes mellitus; Kinase;
KW   Lipoprotein; Myristate; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    505       Tyrosine-protein kinase Blk.
FT                                /FTId=PRO_0000088061.
FT   DOMAIN       58    118       SH3.
FT   DOMAIN      124    220       SH2.
FT   DOMAIN      241    494       Protein kinase.
FT   NP_BIND     247    255       ATP (By similarity).
FT   ACT_SITE    360    360       Proton acceptor (By similarity).
FT   BINDING     269    269       ATP (By similarity).
FT   MOD_RES     389    389       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   LIPID         2      2       N-myristoyl glycine (By similarity).
FT   VARIANT      48     48       T -> I (in dbSNP:rs35339715).
FT                                /FTId=VAR_041672.
FT   VARIANT      71     71       A -> T (associated with MODY11; reduces
FT                                the enhancing effect of BLK on insulin
FT                                secretion; reduces the inducing effect of
FT                                BLK on the expression of PDX1 and NKX6-1;
FT                                found as somatic mutation in a colorectal
FT                                adenocarcinoma sample; dbSNP:rs55758736).
FT                                /FTId=VAR_041673.
FT   CONFLICT    287    287       V -> M (in Ref. 1; CAA83965).
FT   CONFLICT    407    407       I -> Y (in Ref. 2; AAB33265).
SQ   SEQUENCE   505 AA;  57706 MW;  B5F739BEF8389176 CRC64;
     MGLVSSKKPD KEKPIKEKDK GQWSPLKVSA QDKDAPPLPP LVVFNHLTPP PPDEHLDEDK
     HFVVALYDYT AMNDRDLQML KGEKLQVLKG TGDWWLARSL VTGREGYVPS NFVARVESLE
     MERWFFRSQG RKEAERQLLA PINKAGSFLI RESETNKGAF SLSVKDVTTQ GELIKHYKIR
     CLDEGGYYIS PRITFPSLQA LVQHYSKKGD GLCQRLTLPC VRPAPQNPWA QDEWEIPRQS
     LRLVRKLGSG QFGEVWMGYY KNNMKVAIKT LKEGTMSPEA FLGEANVMKA LQHERLVRLY
     AVVTKEPIYI VTEYMARGCL LDFLKTDEGS RLSLPRLIDM SAQIAEGMAY IERMNSIHRD
     LRAANILVSE ALCCKIADFG LARIIDSEYT AQEGAKFPIK WTAPEAIHFG VFTIKADVWS
     FGVLLMEVVT YGRVPYPGMS NPEVIRNLER GYRMPRPDTC PPELYRGVIA ECWRSRPEER
     PTFEFLQSVL EDFYTATERQ YELQP
//
